ADAP Fiscal Year 2027 Funding Request

AIDS Drug Assistance Programs (ADAPs) are a component of the Ryan White HIV/AIDS Program Part B funding line. ADAPs provide life-saving HIV treatments to low income, uninsured and underinsured individuals living with HIV/AIDS in all 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, three U.S. Pacific Territories (Guam, the Commonwealth of the Northern Mariana Islands, and American Samoa) and one Associated Jurisdiction (the Republic of the Marshall Islands). Federal funding for ADAPs has remained relatively unchanged over the last decade, while client enrollment and healthcare costs, including drug prices, have continued to increase. 

In FY2026, ADAPs received $900.3 million in federal funding. For FY2027, NASTAD believes ADAPs must receive a significant increase to deal with current and anticipated funding challenges. To address these shortfalls, ADAPs must receive an increase of $175 million, bringing total funding to $1.075 billion. Of the $175 million increase, $75 million should be allocated through the ADAP base funding awards, and $100 million should be added to the ADAP Emergency Relief Funding, bringing those awards to a total of $175 million.

Click here or use the download link below to view the funding request in full.